Radioligand therapy (RLT) used to treat cardiac metastasis of pancreatic neuroendocrine tumor.

Kieran J Ved Arjun BhattAidan M BurkeMichael C LarkinsDishita PandyaConstantin B Marcu

Published in: Clinical case reports (2024)

Radioligand Therapy (RLT) in the form of [177Lu] Lu-DOTA-TATE (Lutathera®) is a promising treatment for pancreatic neuroendocrine tumors (pNETs) with cardiac metastasis. We present a patient treated with [177Lu] Lu-DOTA-TATE that showed shrinkage of metastasis after four treatments at 7.4 GBq every 8 weeks.

Keyphrases

neuroendocrine tumors
pet ct
left ventricular
pet imaging
case report
computed tomography
mesenchymal stem cells
bone marrow
combination therapy
newly diagnosed
replacement therapy
gestational age
preterm birth